South Dakota Investment Council’s Myriad Genetics MYGN Stock Holding History

South Dakota Investment Council’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,840	Closed	-$274K	–	636
2020 Q4	$274K	Hold	13,840	–	–	0.01%	569
2020 Q3	$180K	Hold	13,840	–	–	﹤0.01%	566
2020 Q2	$157K	Hold	13,840	–	–	﹤0.01%	560
2020 Q1	$198K	Hold	13,840	–	–	0.01%	523
2019 Q4	$377K	Hold	13,840	–	–	0.01%	515
2019 Q3	$396K	Buy	13,840 +2,140	+18%	+$62.4K	0.01%	545
2019 Q2	$325K	Hold	11,700	–	–	0.01%	538
2019 Q1	$388K	Buy	11,700 +2,400	+26%	+$73.1K	0.01%	522
2018 Q4	$270K	Buy	+9,300	New	+$335K	0.01%	534

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

South Dakota Investment Council's MYGN Position: Q1 2021 in Review

South Dakota Investment Council sold out of Myriad Genetics (MYGN) in Q1 2021, closing a stake of 13,840 shares — an estimated $274K sold.

South Dakota Investment Council first reported a position in MYGN in Q4 2018 and held it in 9 quarters. The position peaked at $396K in Q3 2019. 197 funds tracked by Wall St. Rank hold MYGN as of Q1 2021.

South Dakota Investment Council reported no remaining Myriad Genetics position as of Q1 2021 after selling out during the quarter.
South Dakota Investment Council sold 13,840 Myriad Genetics shares in Q1 2021, an estimated $274K.
South Dakota Investment Council first reported a position in Myriad Genetics in Q4 2018 and held it in 9 quarters.
South Dakota Investment Council's Myriad Genetics position peaked at $396K in Q3 2019.
197 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2021.

Based on South Dakota Investment Council's 13F filing for Q1 2021, filed 13 May 2021.